SS-31, NAD+ & MOTS-C: Three Different Paths to Mitochondrial Energy

When people talk about energy, they usually mean how awake, motivated, or physically capable they feel.

Biology uses the word differently.

At the cellular level, energy is largely about ATP — adenosine triphosphate, the molecule cells use to power everything from muscle contraction and nerve signaling to protein synthesis and cellular repair.

And much of that ATP is generated inside the mitochondria.

That is why three very different molecules — SS-31, NAD+, and MOTS-C — have increasingly appeared in the same conversations about mitochondrial energy, cellular metabolism, and healthy aging.

They are sometimes grouped together as if they all “boost energy.”

The reality is more interesting.

Each approaches mitochondrial biology from a different direction.

- SS-31, also known as elamipretide, interacts directly with mitochondrial membranes and cardiolipin.
- NAD+ is a fundamental coenzyme involved in electron transfer and cellular energy metabolism.
- MOTS-C is a mitochondrial-derived peptide involved in metabolic signaling and cellular responses to stress.

Rather than thinking of them as three versions of the same thing, it is more accurate to think of them as three different windows into how cells produce, regulate, and respond to energy.

Why Mitochondria Matter for Cellular Energy

Mitochondria are often described as the powerhouses of the cell.

That phrase is simple, but the biology behind it is remarkably complex.

Nutrients from food — including glucose, fatty acids, and amino acids — are broken down through metabolic pathways that extract electrons.

Those electrons eventually enter the mitochondrial electron transport chain.

The energy released during this process helps create a proton gradient across the inner mitochondrial membrane.

That gradient then powers ATP synthase, the molecular machinery responsible for producing ATP.

ATP becomes the immediately usable energy currency of the cell.

This means healthy mitochondrial energy production depends on much more than simply having enough calories available.

It also depends on:

- Mitochondrial membrane integrity
- Electron transport
- Redox balance
- NAD+/NADH availability
- Oxygen utilization
- Metabolic signaling
- Mitochondrial stress responses
- Cellular adaptation

This is where SS-31, NAD+, and MOTS-C begin to diverge.

SS-31: Targeting Mitochondrial Structure

SS-31 is also known as elamipretide.

It is a small mitochondria-targeting tetrapeptide that has been investigated extensively because of its interaction with cardiolipin.

Cardiolipin is a specialized phospholipid concentrated in the inner mitochondrial membrane.

That membrane is not merely a container.

Its folded structures, called cristae, help organize the machinery responsible for oxidative phosphorylation and ATP production.

Research suggests that elamipretide can bind cardiolipin and influence mitochondrial membrane organization.

This has led researchers to study its effects on:

- Mitochondrial membrane stability
- Cristae organization
- Electron transport
- Reactive oxygen species
- Oxidative stress
- ATP production
- Mitochondrial bioenergetics

In simple terms, SS-31 research asks a structural question:

Can improving the environment around the mitochondrial energy machinery help it function more efficiently?

SS-31 and ATP Production

Mitochondrial ATP production depends heavily on the physical organization of the inner membrane.

When mitochondrial membranes become damaged or cardiolipin becomes altered, electron transport can become less efficient.

This may increase electron leakage and the generation of reactive oxygen species, often abbreviated ROS.

ROS are not inherently bad.

Cells use some reactive oxygen species as signaling molecules.

But excessive oxidative stress can damage proteins, lipids, and DNA.

Elamipretide research has therefore focused on whether stabilizing cardiolipin and mitochondrial membrane architecture can support more efficient cellular energy production while reducing excessive oxidative stress.

Preclinical research has produced encouraging findings across several models of mitochondrial dysfunction.

Clinical results, however, have varied depending on the disease and study.

SS-31 Is Now FDA-Approved for a Specific Disease

An important regulatory development occurred in September 2025.

The FDA approved elamipretide under the brand name Forzinity.

The approved indication is to improve muscle strength in adult and pediatric patients with Barth syndrome who weigh at least 30 kilograms.

Barth syndrome is a rare genetic disorder involving abnormal cardiolipin metabolism and mitochondrial dysfunction.

That makes elamipretide's mitochondrial mechanism particularly relevant to the disease.

However, the approval should be interpreted accurately.

FDA approval for Barth syndrome does not mean SS-31 has been approved as a general energy enhancer, anti-aging therapy, athletic-performance compound, or mitochondrial supplement.

Approved indication and broader research interest are two different things.

NAD+: The Cell's Electron Carrier

If SS-31 research focuses heavily on mitochondrial structure, NAD+ sits much closer to the center of cellular energy chemistry itself.

NAD+ stands for:

Nicotinamide adenine dinucleotide.

It exists primarily in two interconvertible forms:

- NAD+
- NADH

This pair acts as an electron carrier.

During energy metabolism, NAD+ accepts electrons and becomes NADH.

NADH can then transfer those electrons into the mitochondrial electron transport chain.

This process is fundamental to ATP production.

Research reviews describe NAD(H) as one of the most important coenzyme systems involved in mitochondrial energy transduction. :contentReference[oaicite:1]{index=1}

Why the NAD+/NADH Ratio Matters

Energy production is not simply about having “more NAD+.”

The relationship between NAD+ and NADH matters.

Cells continuously cycle between oxidized NAD+ and reduced NADH as nutrients are metabolized.

The NAD+/NADH ratio influences:

- Glycolysis
- The citric acid cycle
- Fatty-acid oxidation
- Mitochondrial electron transport
- ATP synthesis
- Cellular redox state

NAD+ also serves as a substrate for several classes of enzymes.

These include:

- Sirtuins
- PARPs
- CD38-related enzymes

These pathways connect NAD+ metabolism with areas of research involving:

- DNA repair
- Stress responses
- Metabolism
- Mitochondrial biology
- Aging

This explains why NAD+ has become such a large topic in longevity and cellular-energy research.

Does More NAD+ Automatically Mean More Energy?

Not necessarily.

This is where marketing can oversimplify the science.

NAD+ is unquestionably essential for energy metabolism.

But that does not mean increasing NAD+ in every circumstance automatically produces more subjective energy, greater athletic performance, or improved mitochondrial function.

Human physiology regulates NAD+ through multiple synthesis, salvage, and consumption pathways.

The biological effect of changing NAD+ availability can depend on:

- Tissue
- Age
- Metabolic state
- Disease state
- Baseline NAD+ levels
- Route of intervention
- Duration
- Cellular demand

Research therefore distinguishes between the importance of NAD+ biology and claims about specific NAD+-raising interventions.

MOTS-C: A Message From the Mitochondria

MOTS-C approaches mitochondrial energy from an entirely different direction.

MOTS-C stands for:

Mitochondrial Open Reading Frame of the 12S rRNA-c.

It is a 16-amino-acid mitochondrial-derived peptide encoded within the mitochondrial genome.

That discovery helped change the traditional view of mitochondria.

For many years, mitochondria were viewed primarily as energy-producing organelles.

Researchers now increasingly recognize them as signaling hubs capable of communicating information about cellular stress and metabolic conditions.

MOTS-C appears to be part of that communication network. :contentReference[oaicite:2]{index=2}

MOTS-C and Metabolic Signaling

Research suggests that MOTS-C can respond to metabolic stress and influence signaling pathways associated with energy metabolism.

One pathway frequently discussed is AMPK, or AMP-activated protein kinase.

AMPK acts as a cellular energy sensor.

When available cellular energy becomes low, AMPK can shift metabolism toward processes that generate ATP while reducing processes that consume large amounts of energy.

Research on MOTS-C has explored relationships involving:

- AMPK signaling
- Glucose metabolism
- Insulin sensitivity
- Metabolic flexibility
- Cellular stress responses
- Exercise
- Aging
- Inflammatory signaling

MOTS-C has also been reported to move into the cell nucleus under certain stress conditions, where it may influence expression of stress-response genes. :contentReference[oaicite:3]{index=3}

That makes MOTS-C particularly interesting.

Rather than simply participating inside the mitochondria, it may help mitochondria communicate with the nuclear genome.

MOTS-C and Exercise

Exercise places significant metabolic stress on skeletal muscle.

Cells must rapidly increase ATP production and adapt to changing energy demands.

Research has found that mitochondrial-derived peptides appear responsive to exercise and metabolic stress.

Studies in humans have examined how exercise influences circulating MOTS-C and related mitochondrial-derived peptides.

This supports a broader hypothesis:

MOTS-C may participate in the body's natural adaptation to metabolic stress.

However, this does not mean administering MOTS-C has been proven to reproduce all the benefits of exercise in humans.

Much of the stronger mechanistic evidence remains preclinical.

MOTS-C and Metabolic Health

MOTS-C research has also explored associations with:

- Obesity
- Insulin resistance
- Type 2 diabetes
- Aging
- Muscle metabolism

A 2024 systematic review and meta-analysis examined circulating MOTS-C levels across different metabolic states.

The investigators found differences between populations with diabetes and obesity, but the patterns were not uniform.

For example, MOTS-C concentrations were lower in individuals with diabetes, while some obesity subgroup findings moved in the opposite direction. :contentReference[oaicite:4]{index=4}

That complexity is important.

MOTS-C biology appears connected to metabolic state, but researchers are still working to understand exactly what those circulating levels mean.

Three Different Parts of the Mitochondrial Energy Story

This is where the comparison becomes useful.

SS-31 / Elamipretide

Research focuses strongly on:

- Cardiolipin
- Inner mitochondrial membrane structure
- Cristae
- Oxidative stress
- Electron transport
- ATP-generating efficiency

Think:

Mitochondrial structure and machinery.

NAD+

Research focuses on:

- Electron transfer
- Redox chemistry
- NAD+/NADH balance
- ATP synthesis
- Metabolic enzymes
- Sirtuin and DNA-repair pathways

Think:

Cellular energy currency infrastructure.

MOTS-C

Research focuses on:

- Metabolic signaling
- AMPK
- Stress adaptation
- Mitochondria-to-nucleus communication
- Glucose metabolism
- Exercise responses

Think:

Mitochondrial communication and metabolic adaptation.

Why Calling Them an “Energy Stack” Can Be Misleading

On social media, SS-31, NAD+, and MOTS-C are sometimes grouped together as a mitochondrial energy stack.

Mechanistically, it is easy to understand why.

Each is connected to mitochondrial or cellular energy biology.

But scientifically:

There is not established clinical evidence demonstrating that combining SS-31, NAD+, and MOTS-C produces a synergistic energy-enhancing effect in humans.

They have different levels of evidence.

They also have different regulatory statuses.

Elamipretide has an FDA-approved indication for Barth syndrome.

NAD+ is an endogenous coenzyme studied across many areas of metabolism.

MOTS-C remains an experimental mitochondrial-derived peptide with substantial preclinical interest but limited clinical evidence.

Grouping them together can be useful for educational comparison.

It should not be interpreted as evidence of a proven therapeutic combination.

What Does “Cellular Energy” Actually Mean?

Another important distinction is the difference between cellular energy production and feeling energetic.

ATP production can be measured biologically.

Feeling energetic is subjective and can be affected by:

- Sleep
- Nutrition
- Hormones
- Stress
- Cardiovascular fitness
- Mental health
- Medications
- Illness
- Hydration
- Blood glucose

A molecule involved in mitochondrial biology does not automatically function like caffeine or a stimulant.

Mitochondrial energy research is fundamentally about bioenergetics — how cells produce, transfer, and regulate usable energy.

That is different from simply feeling “wired.”

Mitochondrial Energy and Aging

Mitochondrial function changes with age.

Researchers have documented age-associated changes involving:

- Mitochondrial number
- Mitochondrial DNA
- Oxidative phosphorylation
- NAD+ metabolism
- Stress signaling
- Mitophagy
- Metabolic flexibility

This is why SS-31, NAD+, and MOTS-C all appear frequently in healthy-aging research.

They each touch a different part of the mitochondrial system.

But healthy aging is extraordinarily complex.

No single mitochondrial pathway explains aging, and no single intervention has been shown to reverse the entire process.

Why This Research Is Still Exciting

The most interesting part of this field may not be the idea of creating the strongest possible “energy stack.”

It may be what these molecules are teaching researchers about mitochondria themselves.

SS-31 highlights the importance of membrane architecture.

NAD+ highlights the importance of electron transfer and metabolic chemistry.

MOTS-C demonstrates that mitochondria are capable of sending biological signals that influence the rest of the cell.

Together, they show that mitochondria are much more than simple ATP factories.

They are dynamic systems that sense stress, coordinate metabolism, communicate with the nucleus, and adapt to changing energy demands.

The Bottom Line

SS-31, NAD+, and MOTS-C are frequently discussed together because all three intersect with mitochondrial energy and cellular metabolism.

But they should not be treated as interchangeable.

SS-31 / elamipretide primarily draws interest for its interaction with cardiolipin and mitochondrial membrane organization.

NAD+ is a fundamental coenzyme involved in electron transfer, redox chemistry, and ATP production.

MOTS-C is a mitochondrial-derived peptide involved in metabolic signaling, stress adaptation, and mitochondria-to-nucleus communication.

That makes the trio scientifically fascinating.

But the most accurate conclusion is not:

“These three compounds create unlimited cellular energy.”

It is:

Research on SS-31, NAD+, and MOTS-C is helping scientists understand three different layers of mitochondrial energy biology — structure, metabolism, and signaling.

And those three layers may ultimately teach us far more about cellular energy than the word “boost” ever could.

Sources & Further Reading

U.S. Food and Drug Administration — Elamipretide / Forzinity

FDA approved elamipretide in September 2025 for improving muscle strength in certain patients with Barth syndrome.

View FDA Drug Trials Snapshots

National Library of Medicine — NAD(H) in Mitochondrial Energy Transduction

Review examining the role of NAD+/NADH in mitochondrial ATP production and cellular metabolism.

Read the review on PubMed Central

National Library of Medicine — Mitochondrial-Derived Peptides in Energy Metabolism

Review examining MOTS-C and other mitochondrial-derived peptides as metabolic signaling molecules.

Read the review on PubMed Central

Journal of Translational Medicine — MOTS-C, Stress, Metabolism and Aging

Review examining MOTS-C signaling, AMPK, stress adaptation, energy metabolism and aging.

Read the PubMed record

Educational and Research Use Only

This article is provided for educational and research purposes only.

It does not recommend combining, administering, purchasing, or using SS-31, NAD+, MOTS-C, or any other research compound.

Elamipretide has an FDA-approved indication for certain patients with Barth syndrome; that approval should not be interpreted as approval for general energy enhancement, athletic performance, longevity, or other uses.

MOTS-C remains an experimental research peptide, and findings from laboratory or animal studies should not be interpreted as established human clinical outcomes.